Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study

1Department of Internal Medicine II 2Department of Internal Medicine I 3INSERM U943 4Université Paris 6 Pierre et Marie Curie UMR S 943, F-75013, Paris 5Department of Pathology, Hôpital Antoine Béclère, AP-HP, Clamart 6Université Paris-Sud, UFR Médecine, Le Kremlin-Bicêtre, F-94275 7Hematology and Immunology department 8Inserm U-1012, Le Kremlin-Bicêtre, F-94275 9Department of Hematology, Hôpital La Conception, Marseille 10Department of Infectious Diseases, AP-HP, le Kremlin-Bicêtre, F-94275 11Department of Hematology, Groupe Hospitalier Pitié-Salpétrière, AP-HP, F-75013 12Department of Hematology, Centre Hospitalier Sud-Francilien, Corbeil-Essonne 13Department of Infectious Diseases, CHU, Vandoeuvre Les Nancy 14Department of Hematology and 15Department of Infectious Diseases, CHU, Nantes 16Department of Pathology 17Department of Hematology, APHP, Hôpital Necker-Enfants Malades, Paris F-75015 18CNRS UMR 8126, IGR, Villejuif F-94800.
JAIDS Journal of Acquired Immune Deficiency Syndromes (Impact Factor: 4.56). 02/2013; 63(2). DOI: 10.1097/QAI.0b013e31828a77f0
Source: PubMed


Hepatitis C virus (HCV) infection is frequent among HIV infected patients. We describe the characteristics of 6 HIV-HCV coinfected patients with B-cell non-Hodgkin lymphoma (NHL) included in a prospective cohort study of HIV related lymphomas. Five of the six cases had features of marginal zone/lymphoplasmacytic NHL versus one out of 33 HIV only infected patients. Remarkably, anti-HCV treatment led to a hematological response in a patient with splenic marginal zone lymphoma. This supports the role of chronic antigenic stimulation by HCV on lymphomagenesis and further evaluation of HCV antiviral therapy in coinfected patients with NHL.

26 Reads
Show more